Order Article Reprints

Zornhagen KW, Clausen MM, Hansen AE, Law I, McEvoy FJ, Engelholm SA, Kjær A, Kristensen AT. Use of Molecular Imaging Markers of Glycolysis, Hypoxia and Proliferation (¹⁸F-FDG, ⁶⁴Cu-ATSM and ¹⁸F-FLT) in a Dog with Fibrosarcoma: The Importance of Individualized Treatment Planning and Monitoring. Diagnostics. 2015; 5(3):372-382. https://doi.org/10.3390/diagnostics5030372

Zornhagen, Kamilla Westarp, Malene M. Clausen, Anders E. Hansen, Ian Law, Fintan J. McEvoy, Svend A. Engelholm, Andreas Kjær, and Annemarie T. Kristensen. 2015. "Use of Molecular Imaging Markers of Glycolysis, Hypoxia and Proliferation (¹⁸F-FDG, ⁶⁴Cu-ATSM and ¹⁸F-FLT) in a Dog with Fibrosarcoma: The Importance of Individualized Treatment Planning and Monitoring" Diagnostics 5, no. 3: 372-382. https://doi.org/10.3390/diagnostics5030372

Zornhagen, K. W., Clausen, M. M., Hansen, A. E., Law, I., McEvoy, F. J., Engelholm, S. A., Kjær, A., & Kristensen, A. T. (2015). Use of Molecular Imaging Markers of Glycolysis, Hypoxia and Proliferation (¹⁸F-FDG, ⁶⁴Cu-ATSM and ¹⁸F-FLT) in a Dog with Fibrosarcoma: The Importance of Individualized Treatment Planning and Monitoring. Diagnostics, 5(3), 372-382. https://doi.org/10.3390/diagnostics5030372